Plain-English translation of NCT04583254 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new approach to treating locally advanced cervical cancer. Instead of the standard 25 sessions of external radiation therapy, researchers want to see if fewer sessions work just as well when combined with weekly chemotherapy and follow-up brachytherapy (internal radiation). The goal is to make treatment shorter while keeping it effective and manageable for patients.
Standard cervical cancer treatment requires many weeks of radiation therapy, which can be difficult for patients to complete and may cause side effects. This study explores whether reducing the number of radiation sessions could make treatment faster and easier to tolerate without compromising how well it works.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the new shortened radiation regimen or the standard treatment. Both groups will receive weekly chemotherapy during their radiation course, followed by internal radiation therapy (brachytherapy). The study will monitor how well the cancer responds to treatment and how you tolerate the therapy. The trial is currently recruiting participants in Canada and aims to enroll 48 patients total.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Canada